{
  "actions": [
    {
      "acted_at": "2016-05-26", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Ways and Means.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5366-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "district": "8", 
      "name": "Fitzpatrick, Michael G.", 
      "sponsored_at": "2016-05-26", 
      "state": "PA", 
      "thomas_id": "01797", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2016-05-26", 
  "number": "5366", 
  "official_title": "To amend the Internal Revenue Code of 1986 to exclude from gross income for seven years amounts earned from the sale of drugs that demonstrate breakthrough therapies for treating Alzheimer's disease.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Alzheimer's Breakthrough Sunshine Act", 
  "sponsor": {
    "district": "18", 
    "name": "Murphy, Patrick", 
    "state": "FL", 
    "thomas_id": "02117", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2016-05-26", 
  "subjects": [
    "Taxation"
  ], 
  "subjects_top_term": "Taxation", 
  "summary": {
    "as": "Introduced", 
    "date": "2016-05-26", 
    "text": "Alzheimer's Breakthrough Sunshine Act \n\nThis bill amends the Internal Revenue Code to exclude from gross income for seven years amounts received from the sale of certain drugs for treating Alzheimer's disease and related dementias.\n\nThe exclusion applies to the sale of a drug approved or licensed as a disease-modifying treatment for Alzheimer's disease and that has been designated as a breakthrough therapy under the Federal Food, Drug, and Cosmetic Act. The drug must be sold through an arm's length transaction by a holder of the approved application for the drug."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Alzheimer's Breakthrough Sunshine Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Internal Revenue Code of 1986 to exclude from gross income for seven years amounts earned from the sale of drugs that demonstrate breakthrough therapies for treating Alzheimer's disease.", 
      "type": "official"
    }
  ], 
  "updated_at": "2016-06-25T07:08:33-04:00", 
  "url": "http://thomas.loc.gov/cgi-bin/bdquery/z?d114:HR5366:@@@L&summ2=m&"
}